314
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis

, , , , &
Pages 1-5 | Received 12 Mar 2017, Accepted 14 Oct 2017, Published online: 17 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Akshay Athavale, Nazila Jamshidi & Darren M. Roberts. (2020) Incomplete responses to the recommended dose of idarucizumab: a systematic review and pharmacokinetic analysis. Clinical Toxicology 58:8, pages 789-800.
Read now

Articles from other publishers (5)

Ya-ou Liu, Qiu-fen Xie, Zhi-yan Liu, Zhe Wang, Guang-yan Mu, Ya-tong Zhang, Zi-nan Zhao, Dong-dong Yuan, Li-ping Guo, Na Wang, Jing Xiang, Hong-tao Song, Jie Jiang, Qian Xiang & Yi-min Cui. (2022) Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation. Frontiers in Cardiovascular Medicine 9.
Crossref
Maxime Delrue, Lucie Chevillard, Alain Stépanian, Alessandra Dragoni, Laurence Camoin‐Jau, Sébastien Voicu, Isabelle Malissin, Nicolas Deye, Marc Gainnier, Virginie Siguret & Bruno Mégarbane. (2022) Case series of massive direct oral anticoagulant ingestion—Treatment and pharmacokinetics data. European Journal of Clinical Investigation 52:6.
Crossref
Dinesh Jothimani, Mukul Vij, Uday Sanglodkar, Vaibhav Patil, Deepti Sachan, Gomathy Narasimhan, Ilankumaran Kaliamoorthy & Mohamed Rela. (2021) Severe Jaundice in a COVID-19 Patient–Virus or Drug?. Journal of Clinical and Experimental Hepatology 11:3, pages 407-408.
Crossref
Nicola Guglielmo, Daniele Orso, Rosalba Mestroni & Giulia Montanari. (2020) A Case of Liver Failure Due to Dabigatran Treated with Venovenous Hemodiafiltration and Idarucizumab. Current Drug Safety 15:3, pages 227-230.
Crossref
. (2018) Dabigatran-etexilate. Reactions Weekly 1693:1, pages 163-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.